Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001373-33Phase 4Active
Phase 4, open-label, single-arm trial of propofol, sponsored by Region Östergötland. Primary endpoint: Risk of depressed respiration with different propofol doses. Started Aug 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001373-33.